Altered hippocampal synaptic transmission in transgenic mice with astrocyte-targeted enhanced CCL2 expression

Brain, Behavior, and Immunity

Volumn 25, Issue SUPPL. 1, 2011, Pages

  Nelson, Thomas E ^a   Hao, Christine ^a   Manos, Jessica ^a   Ransohoff, R M ^b   Gruol, Donna L ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Chemokine; Electrophysiology; Field potential; Hippocampal slice; Long term potentiation; Post tetanic potentiation; Short term potentiation; Synaptic plasticity; Western blot

Indexed keywords

BETA ACTIN; CD11B ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE 67; GLUTAMATE RECEPTOR 1; METABOTROPIC RECEPTOR 2; METABOTROPIC RECEPTOR 3; MONOCYTE CHEMOTACTIC PROTEIN 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; NEURON SPECIFIC ENOLASE; SYNAPSIN I;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN SLICE; COGNITION; CONTROLLED STUDY; ELECTRIC POTENTIAL; EXCITATORY POSTSYNAPTIC POTENTIAL; FEMALE; HIPPOCAMPUS; LEARNING; LONG TERM EXPOSURE; LONG TERM MEMORY; LONG TERM POTENTIATION; MALE; MEMORY; METABOLOMICS; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHORT TERM MEMORY; SYNAPSE; SYNAPTIC TRANSMISSION; TRANSGENIC MOUSE;

ANIMALS; ASTROCYTES; BLOTTING, WESTERN; CHEMOKINE CCL2; ELECTROPHYSIOLOGY; GENOTYPE; HIPPOCAMPUS; MICE; MICE, TRANSGENIC; NEURONAL PLASTICITY; NEURONS; SYNAPSES; SYNAPTIC TRANSMISSION;

EID: 79955718730     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2011.02.013     Document Type: Article

References (85)

1. Andreasen M., Hablitz J.J. Paired-pulse facilitation in the dentate gyrus: a patch-clamp study in rat hippocampus in vitro. J. Neurophysiol. 1994, 72:326-336.
2. Babcock A.A., Kuziel W.A., Rivest S., Owens T. Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS. J. Neurosci. 2003, 23:7922-7930.
3. Banisadr G., Queraud-Lesaux F., Boutterin M.C., Pelaprat D., Zalc B., Rostene W., Haour F., Parsadaniantz S.M. Distribution, cellular localization and functional role of CCR2 chemokine receptors in adult rat brain. J. Neurochem. 2002, 81:257-269.
4. Bennett J.L., Elhofy A., Canto M.C., Tani M., Ransohoff R.M., Karpus W.J. CCL2 transgene expression in the central nervous system directs diffuse infiltration of CD45(high)CD11b(+) monocytes and enhanced Theiler's murine encephalomyelitis virus-induced demyelinating disease. J. Neurovirol. 2003, 9:623-636.
5. Berman J.W., Guida M.P., Warren J., Amat J., Brosnan C.F. Localization of monocyte chemoattractant peptide-1 expression in the central nervous system in experimental autoimmune encephalomyelitis and trauma in the rat. J. Immunol. 1996, 156:3017-3023.
6. Blasko I., Lederer W., Oberbauer H., Walch T., Kemmler G., Hinterhuber H., Marksteiner J., Humpel C. Measurement of thirteen biological markers in CSF of patients with Alzheimer's disease and other dementias. Dement. Geriatr. Cogn. Disord. 2006, 21:9-15.
7. Blednov Y.A., Bergeson S.E., Walker D., Ferreira V.M., Kuziel W.A., Harris R.A. Perturbation of chemokine networks by gene deletion alters the reinforcing actions of ethanol. Behav. Brain Res. 2005, 165:110-125.
8. Breese G.R., Knapp D.J., Overstreet D.H., Navarro M., Wills T.A., Angel R.A. Repeated lipopolysaccharide (LPS) or cytokine treatments sensitize ethanol withdrawal-induced anxiety-like behavior. Neuropsychopharmacology 2008, 33:867-876.
9. Cartier L., Hartley O., Dubois-Dauphin M., Krause K.H. Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases. Brain Res. Brain Res. Rev. 2005, 48:16-42.
10. Conductier, G., Blondeau, N., Guyon, A., Nahon, J.L., Rovere, C., 2010. The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases. J. Neuroimmunol., June 5 [Epub ahead of print].
11. Creager R., Dunwiddie T., Lynch G. Paired-pulse and frequency facilitation in the CA1 region of the in vitro rat hippocampus. J. Physiol. 1980, 299:409-424.
12. Debanne D., Guerineau N.C., Gahwiler B.H., Thompson S.M. Paired-pulse facilitation and depression at unitary synapses in rat hippocampus: quantal fluctuation affects subsequent release. J. Physiol. 1996, 491:163-176.
13. Dhillon N.K., Williams R., Callen S., Zien C., Narayan O., Buch S. Roles of MCP-1 in development of HIV-dementia. Front. Biosci. 2008, 13:3913-3918.
14. Dingledine R. Possible mechanisms of enkephalin action on hippocampal CA1 pyramidal neurons. J. Neurosci. 1981, 1:1022-1035.
15. Dittman J.S., Kreitzer A.C., Regehr W.G. Interplay between facilitation, depression, and residual calcium at three presynaptic terminals. J. Neurosci. 2000, 20:1374-1385.
16. Dobrunz L.E., Stevens C.F. Heterogeneity of release probability, facilitation, and depletion at central synapses. Neuron 1997, 18:995-1008.
17. Dunwiddie T.V., Haas H.L. Adenosine increases synaptic facilitation in the in vitro rat hippocampus: evidence for a presynaptic site of action. J. Physiol. 1985, 369:365-377.
18. Elhofy A., Wang J., Tani M., Fife B.T., Kennedy K.J., Bennett J., Huang D., Ransohoff R.M., Karpus W.J. Transgenic expression of CCL2 in the central nervous system prevents experimental autoimmune encephalomyelitis. J. Leukoc. Biol. 2005, 77:229-237.
19. Erickson M.A., Maramara L.A., Lisman J. A single brief burst induces GluR1-dependent associative short-term potentiation: a potential mechanism for short-term memory. J. Cogn. Neurosci. 2009, 22:2530-2540.
20. Fisher S.N., Vanguri P., Shin H.S., Shin M.L. Regulatory mechanisms of MuRantes and CRG-2 chemokine gene induction in central nervous system glial cells by virus. Brain Behav. Immun. 1995, 9:331-344.
21. Flugel A., Hager G., Horvat A., Spitzer C., Singer G.M., Graeber M.B., Kreutzberg G.W., Schwaiger F.W. Neuronal MCP-1 expression in response to remote nerve injury. J. Cereb. Blood Flow Metab. 2001, 21:69-76.
22. Foresti M.L., Arisi G.M., Katki K., Montanez A., Sanchez R.M., Shapiro L.A. Chemokine CCL2 and its receptor CCR2 are increased in the hippocampus following pilocarpine-induced status epilepticus. J. Neuroinflamm. 2009, 6:40.
23. Galimberti D., Schoonenboom N., Scheltens P., Fenoglio C., Bouwman F., Venturelli E., Guidi I., Blankenstein M.A., Bresolin N., Scarpini E. Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease. Arch. Neurol. 2006, 63:538-543.
24. Geppert A.M. Constitutive patterns of RANTES, MCP-1 and MIP-1 alpha expression at the mRNA and protein level during postnatal development of the rat brain. Folia Neuropathol. 2003, 41:79-88.
25. Glabinski A.R., Tani M., Strieter R.M., Tuohy V.K., Ransohoff R.M. Synchronous synthesis of alpha- and beta-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis. Am. J. Pathol. 1997, 150:617-630.
26. Guyon A., Skrzydelski D., De Giry I., Rovere C., Conductier G., Trocello J.M., Dauge V., Kitabgi P., Rostene W., Nahon J.L., Melik Parsadaniantz S. Long term exposure to the chemokine CCL2 activates the nigrostriatal dopamine system: a novel mechanism for the control of dopamine release. Neuroscience 2009, 162:1072-1080.
27. He J., Crews F.T. Increased MCP-1 and microglia in various regions of the human alcoholic brain. Exp. Neurol. 2008, 210:349-358.
28. Huang D., Tani M., Wang J., Han Y., He T.T., Weaver J., Charo I.F., Tuohy V.K., Rollins B.J., Ransohoff R.M. Pertussis toxin-induced reversible encephalopathy dependent on monocyte chemoattractant protein-1 overexpression in mice. J. Neurosci. 2002, 22:10633-10642.
29. Huang D., Wujek J., Kidd G., He T.T., Cardona A., Sasse M.E., Stein E.J., Kish J., Tani M., Charo I.F., Proudfoot A.E., Rollins B.J., Handel T., Ransohoff R.M. Chronic expression of monocyte chemoattractant protein-1 in the central nervous system causes delayed encephalopathy and impaired microglial function in mice. FASEB J. 2005, 19:761-772.
30. Iikuni N., Okamoto H., Yoshio T., Sato E., Kamitsuji S., Iwamoto T., Momohara S., Taniguchi A., Yamanaka H., Minota S., Kamatani N. Raised monocyte chemotactic protein-1 (MCP-1)/CCL2 in cerebrospinal fluid of patients with neuropsychiatric lupus. Ann. Rheum. Dis. 2006, 65:253-256.
31. Ishizuka K., Kimura T., Igata-yi R., Katsuragi S., Takamatsu J., Miyakawa T. Identification of monocyte chemoattractant protein-1 in senile plaques and reactive microglia of Alzheimer's disease. Psychiatry Clin. Neurosci. 1997, 51:135-138.
32. Jung H., Toth P.T., White F.A., Miller R.J. Monocyte chemoattractant protein-1 functions as a neuromodulator in dorsal root ganglia neurons. J. Neurochem. 2008, 104:254-263.
33. Kelder W., McArthur J.C., Nance-Sproson T., McClernon D., Griffin D.E. Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia. Ann. Neurol. 1998, 44:831-835.
34. Kielian T., van Rooijen N., Hickey W.F. MCP-1 expression in CNS-1 astrocytoma cells: implications for macrophage infiltration into tumors in vivo. J. Neurooncol. 2002, 56:1-12.
35. Kiyota T., Yamamoto M., Schroder B., Jacobsen M.T., Swan R.J., Lambert M.P., Klein W.L., Gendelman H.E., Ransohoff R.M., Ikezu T. AAV1/2-mediated CNS gene delivery of dominant-negative CCL2 mutant suppresses gliosis, beta-amyloidosis, and learning impairment of APP/PS1 mice. Mol. Ther. 2009, 17:803-809.
36. Kiyota T., Yamamoto M., Xiong H., Lambert M.P., Klein W.L., Gendelman H.E., Ransohoff R.M., Ikezu T. CCL2 accelerates microglia-mediated Abeta oligomer formation and progression of neurocognitive dysfunction. PLoS ONE 2009, 4:e6197.
37. Klein M., Paul R., Angele B., Popp B., Pfister H.W., Koedel U. Protein expression pattern in experimental pneumococcal meningitis. Microbes Infect. 2006, 8:974-983.
38. Lauri S.E., Palmer M., Segerstrale M., Vesikansa A., Taira T., Collingridge G.L. Presynaptic mechanisms involved in the expression of STP and LTP at CA1 synapses in the hippocampus. Neuropharmacology 2007, 52:1-11.
39. Little A.R., Benkovic S.A., Miller D.B., O'Callaghan J.P. Chemically induced neuronal damage and gliosis: enhanced expression of the proinflammatory chemokine, monocyte chemoattractant protein (MCP)-1, without a corresponding increase in proinflammatory cytokines(1). Neuroscience 2002, 115:307-320.
40. Little A.R., Sriram K., O'Callaghan J.P. Corticosterone regulates expression of CCL2 in the intact and chemically injured hippocampus. Neurosci. Lett. 2006, 399:162-166.
41. Losy J., Zaremba J. Monocyte chemoattractant protein-1 is increased in the cerebrospinal fluid of patients with ischemic stroke. Stroke 2001, 32:2695-2696.
42. Lu M., Grove E.A., Miller R.J. Abnormal development of the hippocampal dentate gyrus in mice lacking the CXCR4 chemokine receptor. Proc. Natl. Acad. Sci. USA 2002, 99:7090-7095.
43. Ma Q., Jones D., Borghesani P.R., Segal R.A., Nagasawa T., Kishimoto T., Bronson R.T., Springer T.A. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc. Natl. Acad. Sci. USA 1998, 95:9448-9453.
44. Madrigal J.L., Garcia-Bueno B., Hinojosa A.E., Polak P., Feinstein D.L., Leza J.C. Regulation of MCP-1 production in brain by stress and noradrenaline-modulating drugs. J. Neurochem. 2009, 113:543-551.
45. Madrigal J.L., Garcia-Bueno B., Hinojosa A.E., Polak P., Feinstein D.L., Leza J.C. Regulation of MCP-1 production in brain by stress and noradrenaline-modulating drugs. J. Neurochem. 2010, 113:543-551.
46. Mahad D.J., Ransohoff R.M. The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE). Semin. Immunol. 2003, 15:23-32.
47. Mahajan S.D., Schwartz S.A., Aalinkeel R., Chawda R.P., Sykes D.E., Nair M.P. Morphine modulates chemokine gene regulation in normal human astrocytes. Clin. Immunol. 2005, 115:323-332.
48. Matsumoto I., Alexander-Kaufman K., Iwazaki T., Kashem M.A., Matsuda-Matsumoto H. CNS proteomes in alcohol and drug abuse and dependence. Expert Rev. Proteomics 2007, 4:539-552.
49. McKay B.E., McRory J.E., Molineux M.L., Hamid J., Snutch T.P., Zamponi G.W., Turner R.W. Ca(V)3 T-type calcium channel isoforms differentially distribute to somatic and dendritic compartments in rat central neurons. Eur. J. Neurosci. 2006, 24:2581-2594.
50. Meng S.Z., Oka A., Takashima S. Developmental expression of monocyte chemoattractant protein-1 in the human cerebellum and brainstem. Brain Dev. 1999, 21:30-35.
51. Miller R.J., Rostene W., Apartis E., Banisadr G., Biber K., Milligan E.D., White F.A., Zhang J. Chemokine action in the nervous system. J. Neurosci. 2008, 28:11792-11795.
52. Miyamoto E. Molecular mechanism of neuronal plasticity: induction and maintenance of long-term potentiation in the hippocampus. J. Pharmacol. Sci. 2006, 100:433-442.
53. Muessel M.J., Klein R.M., Wilson A.M., Berman N.E. Ablation of the chemokine monocyte chemoattractant protein-1 delays retrograde neuronal degeneration, attenuates microglial activation, and alters expression of cell death molecules. Brain Res. Mol. Brain Res. 2002, 103:12-27.
54. Murphy P.M., Baggiolini M., Charo I.F., Hebert C.A., Horuk R., Matsushima K., Miller L.H., Oppenheim J.J., Power C.A. International union of pharmacology: XXII. Nomenclature for chemokine receptors. Pharmacol. Rev. 2000, 52:145-176.
55. Okamoto H., Kobayashi A., Yamanaka H. Cytokines and chemokines in neuropsychiatric syndromes of systemic lupus erythematosus. J. Biomed. Biotechnol. 2010, 2010:268436.
56. Otmakhov N., Shirke A.M., Malinow R. Measuring the impact of probabilistic transmission on neuronal output. Neuron 1993, 10:1101-1111.
57. Parachikova A., Cotman C.W. Reduced CXCL12/CXCR4 results in impaired learning and is downregulated in a mouse model of Alzheimer disease. Neurobiol. Dis. 2007, 28:143-153.
58. Qin L., He J., Hanes R.N., Pluzarev O., Hong J.S., Crews F.T. Increased systemic and brain cytokine production and neuroinflammation by endotoxin following ethanol treatment. J. Neuroinflamm. 2008, 5:10.
59. Ramesh G., Borda J.T., Gill A., Ribka E.P., Morici L.A., Mottram P., Martin D.S., Jacobs M.B., Didier P.J., Philipp M.T. Possible role of glial cells in the onset and progression of Lyme neuroborreliosis. J. Neuroinflamm. 2009, 6:23.
60. Rhodes J.K., Sharkey J., Andrews P.J. The temporal expression, cellular localization, and inhibition of the chemokines MIP-2 and MCP-1 after traumatic brain injury in the rat. J. Neurotrauma 2009, 26:507-525.
61. Rock R.B., Gekker G., Hu S., Sheng W.S., Cheeran M., Lokensgard J.R., Peterson P.K. Role of microglia in central nervous system infections. Clin. Microbiol. Rev. 2004, 17:942-964. table of contents.
62. Rock R.B., Hu S., Sheng W.S., Peterson P.K. Morphine stimulates CCL2 production by human neurons. J. Neuroinflamm. 2006, 3:32.
63. Ryabinin A.E. Role of hippocampus in alcohol-induced memory impairment: implications from behavioral and immediate early gene studies. Psychopharmacology (Berl.) 1998, 139:34-43.
64. Sato K., Kuratsu J., Takeshima H., Yoshimura T., Ushio Y. Expression of monocyte chemoattractant protein-1 in meningioma. J. Neurosurg. 1995, 82:874-878.
65. Schulz P.E., Fitzgibbons J.C. Differing mechanisms of expression for short- and long-term potentiation. J. Neurophysiol. 1997, 78:321-334.
66. Silva A.J. Molecular and cellular cognitive studies of the role of synaptic plasticity in memory. J. Neurobiol. 2003, 54:224-237.
67. Silva A.J., Rosahl T.W., Chapman P.F., Marowitz Z., Friedman E., Frankland P.W., Cestari V., Cioffi D., Sudhof T.C., Bourtchuladze R. Impaired learning in mice with abnormal short-lived plasticity. Curr. Biol. 1996, 6:1509-1518.
68. Sokolova A., Hill M.D., Rahimi F., Warden L.A., Halliday G.M., Shepherd C.E. Monocyte chemoattractant protein-1 plays a dominant role in the chronic inflammation observed in Alzheimer's disease. Brain Pathol. 2009, 19:392-398.
69. Song M.Y., Yuan J.X. Introduction to TRP channels: structure, function, and regulation. Adv. Exp. Med. Biol. 2010, 661:99-108.
70. Sorensen T.L., Tani M., Jensen J., Pierce V., Lucchinetti C., Folcik V.A., Qin S., Rottman J., Sellebjerg F., Strieter R.M., Frederiksen J.L., Ransohoff R.M. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J. Clin. Invest. 1999, 103:807-815.
71. Stefini R., Catenacci E., Piva S., Sozzani S., Valerio A., Bergomi R., Cenzato M., Mortini P., Latronico N. Chemokine detection in the cerebral tissue of patients with posttraumatic brain contusions. J. Neurosurg. 2008, 108:958-962.
72. Sun J.H., Yang B., Donnelly D.F., Ma C., LaMotte R.H. MCP-1 enhances excitability of nociceptive neurons in chronically compressed dorsal root ganglia. J. Neurophysiol. 2006, 96:2189-2199.
73. Sutcigil L., Oktenli C., Musabak U., Bozkurt A., Cansever A., Uzun O., Sanisoglu S.Y., Yesilova Z., Ozmenler N., Ozsahin A., Sengul A. Pro- and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy. Clin. Dev. Immunol. 2007, 2007:76396.
74. Tran P.B., Miller R.J. Chemokine receptors: signposts to brain development and disease. Nat. Rev. Neurosci. 2003, 4:444-455.
75. Tribouillard-Tanvier D., Striebel J.F., Peterson K.E., Chesebro B. Analysis of protein levels of 24 cytokines in scrapie agent-infected brain and glial cell cultures from mice differing in prion protein expression levels. J. Virol. 2009, 83:11244-11253.
76. Ubogu E.E., Cossoy M.B., Ransohoff R.M. The expression and function of chemokines involved in CNS inflammation. Trends Pharmacol. Sci. 2006, 27:48-55.
77. van Gassen K.L., Netzeband J.G., de Graan P.N., Gruol D.L. The chemokine CCL2 modulates Ca2+ dynamics and electrophysiological properties of cultured cerebellar Purkinje neurons. Eur. J. Neurosci. 2005, 21:2949-2957.
78. Wheeler D.B., Randall A., Tsien R.W. Roles of N-type and Q-type Ca2+ channels in supporting hippocampal synaptic transmission. Science 1994, 264:107-111.
79. White F.A., Sun J., Waters S.M., Ma C., Ren D., Ripsch M., Steflik J., Cortright D.N., Lamotte R.H., Miller R.J. Excitatory monocyte chemoattractant protein-1 signaling is up-regulated in sensory neurons after chronic compression of the dorsal root ganglion. Proc. Natl. Acad. Sci. USA 2005, 102:14092-14097.
80. Wu Y., Wang X., Mo X., Xi Z., Xiao F., Li J., Zhu X., Luan G., Wang Y., Li Y., Zhang J. Expression of monocyte chemoattractant protein-1 in brain tissue of patients with intractable epilepsy. Clin. Neuropathol. 2008, 27:55-63.
81. Yao H., Peng F., Dhillon N., Callen S., Bokhari S., Stehno-Bittel L., Ahmad S.O., Wang J.Q., Buch S. Involvement of TRPC channels in CCL2-mediated neuroprotection against tat toxicity. J. Neurosci. 2009, 29:1657-1669.
82. You H., Altier C., Zamponi G.W. CCR2 receptor ligands inhibit Cav3.2 T-type calcium channels. Mol. Pharmacol. 2010, 77:211-217.
83. Zhou Y., Tang H., Liu J., Dong J., Xiong H. Chemokine CCL2 modulation of neuronal excitability and synaptic transmission in rat hippocampal slices. J. Neurochem. 2011, 116:406-414.
84. Zhu Y., Yu T., Zhang X.C., Nagasawa T., Wu J.Y., Rao Y. Role of the chemokine SDF-1 as the meningeal attractant for embryonic cerebellar neurons. Nat. Neurosci. 2002, 5:719-720.
85. Zucker R.S., Regehr W.G. Short-term synaptic plasticity. Annu. Rev. Physiol. 2002, 64:355-405.